Aura Biosciences, Inc.
NASDAQ:AURA
Overview | Financials
Company Name | Aura Biosciences, Inc. |
Symbol | AURA |
Currency | USD |
Price | 8.2 |
Market Cap | 409,602,021 |
Dividend Yield | 0% |
52-week-range | 6.63 - 12.378 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Elisabet de los Pinos Ph.D. |
Website | https://www.aurabiosciences.com |
An error occurred while fetching data.
About Aura Biosciences, Inc.
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD